Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Viruses|October 26, 2024
Assessment of a Structurally Modified Alternanthera Mosaic Plant Virus as a Delivery System for Sarcoma CellsDaria Fayzullina, Tatiana Manukhova, Ekaterina Evtushenko, et al.Cancer Letters|February 24, 2019
Cathepsin B: A sellsword of cancer progressionOlja Mijanović, Ana Branković, Alexander N Panin, et al.Molecular Biology Reports|December 15, 2025
Targeting autophagy and metabolism for ewing sarcomaKamilla Antoshina, Denis Aniskin, Mikhail Stempen, et al.Cancer Letters|June 9, 2015
MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivoIlya Ulasov, Anton V Borovjagin, Natalya Kaverina, et al.Frontiers in Oncology|February 28, 2022
FNC: An Advanced Anticancer Therapeutic or Just an Underdog?Daria Fayzullina, Rajesh Kumar Kharwar, Arbind Acharya, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 9, 2023
The spectrum of cell death in sarcomaElizaveta Belyaeva, Nina Loginova, Brett A Schroeder, et al.Journal of Neuroimmunology|March 1, 2006
Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapySimona Velicu, Yu Han, Ilya Ulasov, et al.Cancers|November 26, 2022
Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to SurvivalSemyon Yakushov, Maxim Menyailo, Evgeny Denisov, et al.Journal of Bone Oncology|July 20, 2022
Latest developments in the pathobiology of Ewing sarcomaIrina Karlina, Brett A Schroeder, Kirill Kirgizov, et al.Cancers|April 23, 2022
Novel Targeted Therapeutic Strategies for Ewing SarcomaDaria Fayzullina, Sergey Tsibulnikov, Mikhail Stempen, et al.Pageof 5